ISSN: 2376-127X

Journal of Pregnancy and Child Health
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Research Article   
  • JPCH,
  • DOI: 10.4172/2376-127X.1000595

The Effect of a Novel Multi-Ingredient Supplement in Pregnant Women

Marco Rigatti1, Agostino Menditto2, Renato De Stefano2*, Civetta Antonio3, Umberto Landri4, Roberto Passaro4, Mario Passaro4, Fabrizio Paolillo Diodati4, Alessandro Nicotra4, Emio Cafarelli4, Ermanno Barletta4, Antonio Esposito4 and Pierluigi Pozzuoli4
1Clinica Sanatrix, Naples, Italy
2Clinica Mediterranea, Naples, Italy
3Andrea Grimaldi Medical Care, Naples, Italy
4Naples, Italy
*Corresponding Author : Renato De Stefano, Grimaldi Clinic, Naples, Italy, Email: destefanorenato29@gmail.com

Received Date: Jun 01, 2023 / Accepted Date: Jun 30, 2023 / Published Date: Jun 30, 2023

Abstract

Objective: to investigate the effects of a novel multi-ingredient supplement comprised of high dose whey protein, to improve maternal and perinatal outcomes in pregnant women

Methods: This was an observational retrospective study. Women who received oral supplementation with a novel multi-ingredient supplement (PSIPROTO ®), comprised of high dose whey protein, were compared with women who did not. Inclusion criteria were singleton pregnancy with body mass index (BMI) higher than 25. The primary outcome of the study was the incidence of adverse pregnancy outcome

Results: 400 women, 200 for each group, were included in the study. The two groups were similar in terms of maternal demographics, and both of them had similar BMI. Maternal age and smoking rate were also similar. Women who received the intervention had a significantly lower maternal weight gain, and lower risk of low birth weight. Notably, 4 women in the intervention group reported intrauterine growth restriction before the intervention, and solved after 2 months of supplementation.

Conclusion: Our retrospective cohort of singleton gestations with BMI >25 showed that PSIPROTO is a safe and efficacy supplement in pregnancy.

Citation: Rigatti M, Menditto A, Stefano RD, Antonio C, Landri U, et al. (2023) The Effect of a Novel Multi-Ingredient Supplement in Pregnant Women. J Preg Child Health 10: 595. Doi: 10.4172/2376-127X.1000595

Copyright: © 2023 Rigatti M, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Top